The primary outcome was clinical improvement in pouchitis at 4 weeks after FMT assessed by patient surveys; secondary outcomes included decreases in composite PDAI at least 3 at week 4, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and fecal calprotectin compared to baseline. This evidence concerns the gene CRP and pouchitis.